vimarsana.com

Page 14 - Pascal Soriot News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher

The latest investor updates on stocks that are trending on Tuesday.

United kingdomDipak golechhaDevin nunesPascal soriotPalo alto networkTrump media technology groupPalo alto networksTrump mediaTechnology groupTruth socialBig tech

AstraZeneca lays out plans to hit $80bn in revenues by 2030

AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Pascal soriot

AstraZeneca Targets $80B Revenue by 2030 with New Medicines

AstraZeneca aims for a 75% revenue boost to $80 billion by 2030, driven by 20 new medicines and growth in existing portfolios. CEO Pascal Soriot has revitalized the drug pipeline with key blockbusters. Analysts anticipate key insights at today's investor day event.

City ofUnited kingdomPascal soriotJames gordonJp morganNovo nordiskEmily field

FTSE 100 live: Blue-chips fall out of bed, Pennon hits water companies, AstraZeneca rises

FTSE 100 live: Blue-chips fall out of bed, Pennon hits water companies, AstraZeneca rises
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesHong kongCity ofMerthyr tydfilHargreaves lansdownPascal soriotAmena bakrBen broadbentAsia dowJamie dimonPaul kelsoAsia pacificAndrew baileyThierry garnierFraser mckevitt

AstraZeneca Plc aims for $80 billion in revenue by 2030

AstraZeneca Plc aims for $80 billion in revenue by 2030

United kingdomPascal soriotTotal revenueChief executive officerInvestor day

vimarsana © 2020. All Rights Reserved.